Researchers report development of rapid, low-cost test for detecting TB in resource-limited areas

Tuberculosis (TB) is a highly infectious disease and a major global health problem, especially in countries with developing health care systems. Because there is no fast, easy way to detect TB, the deadly infection can spread quickly through communities. Now, a team reports in ACS Sensors the development of a rapid, sensitive and low-cost method for detecting the disease in resource-limited areas.

The typical way that physicians screen for TB, which is caused by the bacterium Mycobacterium tuberculosis (Mtb), is with a tuberculin skin test or an examination of a patient's sputum under a microscope. To weed out false positives, a more reliable test that involves growing Mtb cultures can be performed, but that requires weeks to complete. For all of these methods, experienced personnel are needed. Another approach that is both quick and accurate is a nucleic acid amplification test, which makes many copies of the Mtb DNA in a sample. However, it is expensive and requires a lab setting. So, Matt Trau, Nicholas P. West and colleagues set out to create a simple, inexpensive and reliable way to quickly test for TB.

The researchers began with a newly created nucleic acid amplification test that does not require expensive lab equipment to detect Mtb. Still, this modified test typically uses costly fluorescence technology to read the results. So the team substituted the fluorescence detector with a colorimetric assay that changes to a blue hue if the infection is present, allowing health care workers to identify positive test results right away with the naked eye. They demonstrated how the modified diagnostic could be put on cheap, disposable electrochemical sensors for increased sensitivity, even in the field. Because the assay is inexpensive, quick and highly specific for the Mtb bacterium, the researchers say it could have a big impact in low-resource communities.

Source: American Chemical Society

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New $5.8 million grant aims to transform the global landscape of TB research